[go: up one dir, main page]

DE69725023D1 - Katalytische asymmetrische epoxidierung - Google Patents

Katalytische asymmetrische epoxidierung

Info

Publication number
DE69725023D1
DE69725023D1 DE69725023T DE69725023T DE69725023D1 DE 69725023 D1 DE69725023 D1 DE 69725023D1 DE 69725023 T DE69725023 T DE 69725023T DE 69725023 T DE69725023 T DE 69725023T DE 69725023 D1 DE69725023 D1 DE 69725023D1
Authority
DE
Germany
Prior art keywords
catalytic asymmetric
asymmetric epoxy
epoxy
catalytic
olefin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69725023T
Other languages
English (en)
Other versions
DE69725023T2 (de
Inventor
Yian Shi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Colorado State University Research Foundation
Original Assignee
Colorado State University Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Colorado State University Research Foundation filed Critical Colorado State University Research Foundation
Publication of DE69725023D1 publication Critical patent/DE69725023D1/de
Application granted granted Critical
Publication of DE69725023T2 publication Critical patent/DE69725023T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B53/00Asymmetric syntheses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D301/00Preparation of oxiranes
    • C07D301/02Synthesis of the oxirane ring
    • C07D301/03Synthesis of the oxirane ring by oxidation of unsaturated compounds, or of mixtures of unsaturated and saturated compounds
    • C07D301/12Synthesis of the oxirane ring by oxidation of unsaturated compounds, or of mixtures of unsaturated and saturated compounds with hydrogen peroxide or inorganic peroxides or peracids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/04Compounds containing oxirane rings containing only hydrogen and carbon atoms in addition to the ring oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/08Compounds containing oxirane rings with hydrocarbon radicals, substituted by halogen atoms, nitro radicals or nitroso radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/12Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/14Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by free hydroxyl radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/12Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/16Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by esterified hydroxyl radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/12Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/38Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D303/40Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals by ester radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/38Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D303/40Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals by ester radicals
    • C07D303/42Acyclic compounds having a chain of seven or more carbon atoms, e.g. epoxidised fats
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/06Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/10Spiro-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/0803Compounds with Si-C or Si-Si linkages
    • C07F7/0825Preparations of compounds not comprising Si-Si or Si-cyano linkages
    • C07F7/083Syntheses without formation of a Si-C bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • C07F7/1872Preparation; Treatments not provided for in C07F7/20
    • C07F7/1892Preparation; Treatments not provided for in C07F7/20 by reactions not provided for in C07F7/1876 - C07F7/1888
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/02Monosaccharides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H9/00Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
    • C07H9/02Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing only oxygen as ring hetero atoms
    • C07H9/04Cyclic acetals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epoxy Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE69725023T 1996-10-08 1997-10-08 Katalytische asymmetrische epoxidierung Expired - Fee Related DE69725023T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2800996P 1996-10-08 1996-10-08
US28009P 1996-10-08
PCT/US1997/018310 WO1998015544A1 (en) 1996-10-08 1997-10-08 Catalytic asymmetric epoxidation

Publications (2)

Publication Number Publication Date
DE69725023D1 true DE69725023D1 (de) 2003-10-23
DE69725023T2 DE69725023T2 (de) 2004-08-05

Family

ID=21841037

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69725023T Expired - Fee Related DE69725023T2 (de) 1996-10-08 1997-10-08 Katalytische asymmetrische epoxidierung

Country Status (9)

Country Link
US (1) US6348608B1 (de)
EP (1) EP1021426B1 (de)
JP (1) JP2001502316A (de)
AT (1) ATE250048T1 (de)
AU (1) AU4898797A (de)
CA (1) CA2268255A1 (de)
DE (1) DE69725023T2 (de)
ES (1) ES2207721T3 (de)
WO (1) WO1998015544A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6686483B2 (en) 1996-10-08 2004-02-03 Colorado State University Research Foundation Catalytic asymmetric epoxidation
US6613918B1 (en) 2000-10-20 2003-09-02 Bioavailability Systems, Llc Synthesis of spiro ortho esters, spiro ortho carbonates, and intermediates
US6409769B1 (en) * 1998-04-16 2002-06-25 Colorado State University Research Foundation Kinetic resolution of olefins
EP2409985A3 (de) 1996-10-18 2013-05-01 Vertex Pharmaceuticals Incorporated Inhibitoren von Serinproteasen, insbesondere von NS3-Protease des Hepatitis-C-Virus
SV2003000617A (es) 2000-08-31 2003-01-13 Lilly Co Eli Inhibidores de la proteasa peptidomimetica ref. x-14912m
WO2004037827A1 (en) 2000-10-20 2004-05-06 Bioavailability Systems, Llc Synthesis of spiro ortho esters, spiro ortho carbonates, and intermediates
JPWO2002092587A1 (ja) * 2001-05-11 2004-08-26 鐘淵化学工業株式会社 光学活性エポキシドの取得方法
DE10136485C1 (de) * 2001-07-27 2003-03-06 Bayer Ag Polyaminosäure-katalysiertes Verfahren zur enantioselektiven Epoxidierung von alpha,ß-ungesättigten Eonen und alpha,ß-ungesättigten Sulfonen
AU2003219702A1 (en) * 2002-02-04 2003-09-02 Colorado State University Research Foundation Asymmetric epoxidation of electron deficient olefins
TWI359147B (en) 2003-09-05 2012-03-01 Vertex Pharma Inhibitors of serine proteases, particularly hcv n
EP2256113A1 (de) * 2005-08-02 2010-12-01 Vertex Pharmaceuticals Incorporated Serinprotease-Hemmer
US7964624B1 (en) 2005-08-26 2011-06-21 Vertex Pharmaceuticals Incorporated Inhibitors of serine proteases
AR055395A1 (es) * 2005-08-26 2007-08-22 Vertex Pharma Compuestos inhibidores de la actividad de la serina proteasa ns3-ns4a del virus de la hepatitis c
EP1770094A1 (de) * 2005-09-26 2007-04-04 Institut Catala D'Investigacio Quimica Effiziente Synthese von asymmetrischem Epoxidierungs-Katalysator I
EP1770095A1 (de) * 2005-09-26 2007-04-04 Institut Catala D'Investigacio Quimica Effiziente Katalysatoren zur asymmetrischen Epoxidierung von mit Elektronenmangel sowie ohne Elektronenmangel Alkenen
CA2643688A1 (en) 2006-02-27 2007-08-30 Vertex Pharmaceuticals Incorporated Co-crystals and pharmaceutical compositions comprising the same
KR20080112303A (ko) 2006-03-16 2008-12-24 버텍스 파마슈티칼스 인코포레이티드 중수소화 c형 간염 프로테아제 억제제
US20070244334A1 (en) 2006-03-16 2007-10-18 Tanoury Gerald J Processes and intermediates for preparing steric compounds
JP2010519329A (ja) * 2007-02-27 2010-06-03 バーテックス ファーマシューティカルズ インコーポレイテッド セリンプロテアーゼ阻害剤
DK2114924T3 (da) * 2007-02-27 2012-04-10 Vertex Pharma Co-krystaller og farmaceutiske sammensætninger omfattende disse
WO2009032198A1 (en) * 2007-08-30 2009-03-12 Vertex Pharmaceuticals Incorporated Co-crystals and pharmaceutical compositions comprising the same
CN110128439B (zh) * 2018-02-08 2020-12-01 凯特立斯(深圳)科技有限公司 一种氧杂螺环化合物及其合成与拆分方法
EP3898641A1 (de) * 2018-12-20 2021-10-27 DSM IP Assets B.V. Verbesserte synthese eines epoxidationskatalysators

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5414078A (en) 1991-04-05 1995-05-09 Emory University Preparation of 3'-substituted-2',3'-dideoxynucleosides and 2'-deoxynucleosides from acyclic, achiral precursors
US5403549A (en) * 1993-11-04 1995-04-04 Cyclo3 pss Medical Systems, Inc. Method for sterilization using a fluid chemical biocide

Also Published As

Publication number Publication date
CA2268255A1 (en) 1998-04-16
ATE250048T1 (de) 2003-10-15
WO1998015544A1 (en) 1998-04-16
EP1021426A4 (de) 2000-07-26
AU4898797A (en) 1998-05-05
EP1021426B1 (de) 2003-09-17
DE69725023T2 (de) 2004-08-05
JP2001502316A (ja) 2001-02-20
EP1021426A1 (de) 2000-07-26
ES2207721T3 (es) 2004-06-01
US6348608B1 (en) 2002-02-19

Similar Documents

Publication Publication Date Title
DE69725023D1 (de) Katalytische asymmetrische epoxidierung
PT1042314E (pt) Metodo de preparacao de oxidos de tetra-hidrobenzotiepina enantiomericamente enriquecidos
DE3681641D1 (de) Verfahren zur herstellung von amagnetischen bohrstrangteilen.
ATE226949T1 (de) Verfahren zur herstellung von tolterodin
NO953617L (no) Fremgangsmåte for rensing av taxoider
ES2139771T3 (es) Codificador convolucional perforado.
DK0521099T3 (da) Chirale katalysatorer og epoxidationsreaktioner katalyseret derved
DK0643626T3 (da) Fremgangsmåde til fremstilling af epoxychromaner med en chiral katalysator
FR2711818B1 (fr) Procédé de diffusion de données à train de données.
FI855165A7 (fi) Menetelmä metaanin valmistamiseksi tioresistentin katalysaattorin avulla sekä katalysaattori menetelmän suorittamiseksi.
WO2002009379A3 (en) Transmission of main and auxilliary data using pulse width modulation
DE3684052D1 (de) Verfahren zur herstellung von vorverlaengerten epoxidharz-zusammensetzungen.
DE69836076D1 (de) Verfahren für die reverse transkription
IS6433A (is) Aðferð til framleiðslu á sítalóprami
DE60122505D1 (de) Enzymatische umsetzung von epoxiden
EA199900027A1 (ru) Способ получения некоторых азациклогексапептидов
DE3684360D1 (de) Verfahren zur herstellung von epoxidharzen.
DE3680187D1 (de) Verfahren zur herstellung von 3-chlor-1,2-propandiol.
FR2785831B1 (fr) Support monolithe poreux d'un element de filtration et element de filtration
DE69916030D1 (de) Verfahren zur herstellung optisch aktiver threo-3-amino-1,2-epoxyverbindungen
EA199900772A1 (ru) Способ селективного эпоксидирования для получения лекарственных соединений
EP0680076A3 (de) Verfahren zur Herstellung des Kanalbereichs einer Halbleiteranordnung.
MY129351A (en) Method and apparatus for editing data streams
DE3765651D1 (de) Verfahren zur herstellung einer synthesefaser und einer orientierten synthesefaser sowie nach diesem verfahren hergestellte orientierte synthesefaser.
DE69833198D1 (de) Mehrkanalverbindung mit reduzierter spitzen- zu durchschnittamplitude

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee